These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 582011)

  • 1. On the mechanism of amphetamine-induced behavioural changes in the mouse. III. Effects of apomorphine and Fla 63.
    Thomas KV; Handley SL
    Arzneimittelforschung; 1978; 28(6):993-7. PubMed ID: 582011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of amphetamine-induced behavioural changes in the mouse. II. Effects of agents stimulating noradrenergic receptors.
    Handley SL; Thomas KV
    Arzneimittelforschung; 1978; 28(5):834-7. PubMed ID: 373774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanism of amphetamine-induced behavioural changes in the mouse. I. An observational analysis of dexamphetamine.
    Thomas KV; Handley SL
    Arzneimittelforschung; 1978; 28(5):827-33. PubMed ID: 581964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of catecholamines on dexamphetamine-induced changes in locomotor activity.
    Handley SL; Thomas KV
    Psychopharmacology (Berl); 1978 Jul; 58(3):283-8. PubMed ID: 98799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of dexamphetamine-induced compulsive gnawing--including the possible involvement of presynaptic alpha-adrenoreceptors.
    Thomas KV; Handley SL
    Psychopharmacology (Berl); 1978 Jan; 56(1):61-7. PubMed ID: 203967
    [No Abstract]   [Full Text] [Related]  

  • 7. A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration.
    Bailey RC; Jackson DM
    Psychopharmacology (Berl); 1978 Apr; 56(3):317-26. PubMed ID: 418441
    [No Abstract]   [Full Text] [Related]  

  • 8. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.
    Fray PJ; Sahakian BJ; Robbins TW; Koob GF; Iversen SD
    Psychopharmacology (Berl); 1980; 69(3):253-9. PubMed ID: 6774363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central action of nomifensine.
    Maj J; Kapturkiewicz Z; Michaluk J
    Pol J Pharmacol Pharm; 1976; 28(6):557-62. PubMed ID: 189291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J; Lewander T
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract]   [Full Text] [Related]  

  • 12. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
    Dunstan R; Jackson DM
    Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of d-amphetamine and apomorphine in the hamster.
    Peterson ME; Morin LP
    Pharmacol Biochem Behav; 1984 Jun; 20(6):855-8. PubMed ID: 6540446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of carbon disulfide and FLA-63 on operant behavior in pigeons.
    Levine TE
    J Pharmacol Exp Ther; 1976 Dec; 199(3):669-78. PubMed ID: 994023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic activity of some apomorphine analogs.
    Cheng HC; Long JP; Van Orden LS; Cannon JG; O'Donnell JP
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):89-106. PubMed ID: 968179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.